Nature Communications (Jun 2022)
Peripherally restricted transthyretin-based delivery system for probes and therapeutics avoiding opioid-related side effects
Abstract
The current peripherally acting mu-opioid receptor antagonists present limited permeability and pharmacokinetic properties. Here, the authors develop a drug delivery approach based on AG10, which demonstrates the impact of mu-opioid receptors in the central nervous system in precipitating opioid-induced constipation.